Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Letrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 309 Polycystic Ovary Syndrome 33 Neoplasm Metastasis 19 Endometrial Neoplasms 19 Ovarian Neoplasms 14 Neoplasms 10 Advanced Breast Cancer 8 Recurrence 7 Infertility 7 Fallopian Tube Neoplasms 7 Carcinoma, Intraductal, Noninfiltrating 6 Breast Neoplasms, Male 6 Triple Negative Breast Neoplasms 5 Osteoporosis 5 Carcinoma, Lobular 5 Carcinoma, Ductal, Breast 5 Prostatic Neoplasms 4 Leiomyoma 4 Hereditary Sensory and Autonomic Neuropathies 4 Breast Diseases 4 Breast Carcinoma In Situ 4 Breast Cancer Metastatic 4 Arthralgia 4 Neoplasms, Hormone-Dependent 3 Infertility, Female 3 Carcinoma, Ovarian Epithelial 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2

Interventions

Hyperthermic Intraperitoneal Chemotherapy 21 Paclitaxel 20 Cisplatin 17 Cytoreduction Surgical Procedures 16 Oxaliplatin 13 Carboplatin 12 Fluorouracil 9 Bevacizumab 9 Mitomycin 6 Doxorubicin 6 Leucovorin 5 Docetaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Blood Specimen Collection 4 sodium thiosulfate 3 catumaxomab 3 Gemcitabine 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 130-nm albumin-bound paclitaxel 3 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2 liposomal doxorubicin 2 Taxes 2 Palliative Care 2 Observation 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04111978 2025-09-29

MATAO

Swiss GO Trial Group

Phase 3 Recruiting

Fallopian Tube Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡